BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 6484357)

  • 1. [Elaboration of a national reference preparation of lyophilized tetanus antitoxin].
    González Pacheco M; Pérez de la Mora C; Ruíz Puente J; Pérez de la Mora S
    Rev Latinoam Microbiol; 1984; 26(1):9-13. PubMed ID: 6484357
    [No Abstract]   [Full Text] [Related]  

  • 2. [Development of the production of specific human immunoglobulins. III. Production of a test lot of specific anti-tetanus immunoglobulin].
    Coria Jiménez R; Pérez de la Mora C; González Pacheco M; Villalva Posada H
    Rev Latinoam Microbiol; 1984; 26(1):1-7. PubMed ID: 6484352
    [No Abstract]   [Full Text] [Related]  

  • 3. An attempt at using a monospecific tetanus antitoxin as a national reference preparation for flocculation tests.
    Vrancheva S; Valchev V; Gakev V; Bachev S
    Prog Immunobiol Stand; 1967; 3():341-5. PubMed ID: 4985513
    [No Abstract]   [Full Text] [Related]  

  • 4. [Preparation of highly potent lyophilized tetanus antitoxin (author's transl)].
    Huang RJ; Liau MY; Lee JD
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1981 Jun; 14(2):92-5. PubMed ID: 6796352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of immunospecifically isolated tetanus antibodies.
    Varró R
    Ann Immunol Hung; 1973; 17():93-100. PubMed ID: 4142680
    [No Abstract]   [Full Text] [Related]  

  • 6. The British Reference preparation for tetanus antitoxin for the flocculation test.
    Sheffield F; Baldwin PW; Knight PA; Richer PR
    J Biol Stand; 1979; 7(4):301-6. PubMed ID: 536375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The selection of plasma for the preparation of antitetanus immunoglobulin.
    Entwistle CC; Eldridge PL
    Vox Sang; 1973 Sep; 25(3):240-4. PubMed ID: 4744684
    [No Abstract]   [Full Text] [Related]  

  • 8. [On duration of protection with dry immune homologous antitetanus plasma].
    Malyĭ GP; Tomenko EK
    Zh Mikrobiol Epidemiol Immunobiol; 1969; 46(6):123-6. PubMed ID: 5346263
    [No Abstract]   [Full Text] [Related]  

  • 9. [Isolation of anti-tetanus antibodies from diatherm-3 serum on immunosorbents].
    Freĭman VB; Mertsalova NU
    Zh Mikrobiol Epidemiol Immunobiol; 1968 Mar; 45(3):124-7. PubMed ID: 5729692
    [No Abstract]   [Full Text] [Related]  

  • 10. [Chemical composition of diphtheria and tetanus antibodies isolated from the same antidiphtheric-antitetanic horse serum].
    Raĭkher II; Koĭdan LI; Protserova NM
    Biokhimiia; 1969; 34(6):1144-50. PubMed ID: 5392950
    [No Abstract]   [Full Text] [Related]  

  • 11. [Development of the production of specific human immunoglobulins. I. Titration of tetanus antitoxin in the process of obtaining normal human immunoglobulins].
    Pérez de la Mora C; Mayorga Reyes L; González-Pacheco M; Ruiz Puente J
    Rev Latinoam Microbiol; 1983; 25(3):145-54. PubMed ID: 6672933
    [No Abstract]   [Full Text] [Related]  

  • 12. [Biological properties of immunochemically pure tetanus antitoxin].
    Kornilova AV; Khavkin IuA; Batalova TA; Aleksevich IaI; Baschenko IA
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Feb; (2):66-70. PubMed ID: 6340393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunochemical activity of different isoelectric zones of diphtheria and tetanus antitoxins in immune sera].
    Kiriukhin IF; Kiriukhina DN
    Vopr Med Khim; 1973; 19(6):600-3. PubMed ID: 4212671
    [No Abstract]   [Full Text] [Related]  

  • 14. Preparation of active insoluble pepsin.
    Rao SS; Patki VM; Kulkarni AD
    Indian J Biochem; 1970 Sep; 7(3):210-1. PubMed ID: 4252584
    [No Abstract]   [Full Text] [Related]  

  • 15. [A gel filtration study of the fractional composition of tetanus antitoxic sera].
    Runova VF; Kargina TM; Gavrilenkova VIu; Selezneva VP
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Jun; (6):46-8. PubMed ID: 1887709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Behavior of antitoxin titers and of antiserum antibodies after adminstration of tetanus antiserum in humans].
    Lo Sardo S; Catania S; Collarile P
    G Mal Infett Parassit; 1966 Oct; 18(10):673-5. PubMed ID: 5997198
    [No Abstract]   [Full Text] [Related]  

  • 17. [Admixtures present in antitoxic horse sera and pepsin preparations].
    Trubitsina VI; Urykova VA; Chernobel' TP; Noskova VV; Panina NP
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Apr; (4):95-101. PubMed ID: 87071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experiments on the standardization and keeping properties of tetanus antitoxin in the tropics.
    GOYAL RK
    J Trop Med Hyg; 1948 Dec; 51(12):259-63. PubMed ID: 18102797
    [No Abstract]   [Full Text] [Related]  

  • 19. [Preparation of antitoxin fragments from "Diaferm-3 IEM" antitetanus serum].
    Kryzhanovskiĭ GN; Kulygina RM
    Biull Eksp Biol Med; 1972 Oct; 73(10):67-70. PubMed ID: 4628947
    [No Abstract]   [Full Text] [Related]  

  • 20. Collaborative study for the establishment of two European Pharmacopoeia Biological Reference Preparations for serological potency testing of tetanus vaccines for veterinary use.
    Lensing HH; Behr-Gross ME; Daas A; Spieser JM
    Dev Biol (Basel); 2002; 111():69-76. PubMed ID: 12678226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.